COMPARE OPTIONS

Last Updated: March 17, 2026

At-Home Ketamine vs IV Infusions: How Mindbloom Compares

This article compares Mindbloom's at-home ketamine therapy program with IV ketamine clinic treatment across the factors that matter most to patients: administration methods, clinical oversight, integration support, cost, and published outcomes data.

Key takeaways

  • IV ketamine clinics vary in whether they publish peer-reviewed outcomes from their own patients, and many rely on the broader ketamine literature. Mindbloom has published three peer-reviewed studies of its own clients; in one of 1,247 clients (Hull 2022), 89% reported improvement in depression and anxiety symptoms after four sessions.
  • Mindbloom is approximately 60% more affordable per session than typical IV ketamine clinics, which, as of October 2026, generally charge $400 to $800 or more per infusion. IV infusions are rarely covered by insurance; Mindbloom programs are HSA/FSA eligible.
  • Higher bioavailability doesn't by itself mean better outcomes. Sublingual ketamine absorbs at about 30% (Rolan et al., 2014) and IV at close to 100%, yet published depression response is comparable: 56.4% for Mindbloom clients by session 4 (Mathai 2024) vs. 53.6% for IV (McInnes 2022).5,7,12 Bioavailability is how much of a dose reaches the bloodstream, and doses are calibrated to each route.
  • Mindbloom builds 1:1 preparation and integration coaching with a dedicated guide into every program, while at IV clinics it varies: some pair infusions with ketamine-assisted psychotherapy, and others refer clients to external therapists.
  • IV clinics track vitals continuously during the infusion with on-site medical staff. Mindbloom uses telehealth clinician oversight and a required at-home peer treatment monitor, and in its published peer-reviewed studies serious adverse events occurred in fewer than 0.1% of participants.

Quick Comparison of Mindbloom and IV Ketamine

The primary differences between Mindbloom and IV ketamine are cost, treatment setting, and the overall care model. Mindbloom provides a clinician-supervised at-home program with built-in integration coaching, while IV ketamine involves in-person infusions at a medical clinic. Both approaches offer distinct advantages depending on your clinical needs, budget, and logistical preferences.

Ketamine has been an FDA-approved anesthetic since 1970 and has been included on the WHO Model List of Essential Medicines since 1985. Both Mindbloom and IV clinics use off-label prescribing to deliver sub-anesthetic doses for mental health conditions. Off-label prescribing is a widespread, legally accepted medical practice: about 21% of U.S. office-based prescriptions are written for off-label uses (Radley et al., 2006).2

Mindbloom vs IV Ketamine at a Glance

FeatureMindbloom (At-Home)IV Ketamine Clinic
SettingHome-basedIn-clinic
Administration methodsSublingual tablets, subcutaneous injectionIntravenous infusion
Bioavailability rangeVaries by route (sublingual ~30%, subcutaneous ~90%+)~100%
Published depression response56.4% with sublingual tablets by session 4 (Mathai 2024)5; 56.6% with subcutaneous injections by the end of the six-session course (Parks 2026)653.6% (McInnes 2022)7
Clinical oversightTelehealth clinician consults, required peer treatment monitorOn-site medical staff, vitals monitoring
Integration & coaching1:1 sessions with a dedicated guide, Group Integration Circles, unlimited messagingVaries; many clinics offer infusion only
Published research on own protocolThree peer-reviewed studies (Hull 2022, Mathai 2024, Parks 2026)Varies by clinic; many cite general ketamine literature
Subcutaneous optionYes (only at-home provider)No (IV only)
Approximate cost per session~60% more affordable per session than IV clinicsTypically $400–$800+ per infusion (as of October 2026)
InsuranceHSA/FSA eligible; superbills availableRarely covered; some clinics offer superbills
AccessibilityAvailable in 38 states; no travel requiredLimited to clinic locations; requires travel

What Is Mindbloom?

Mindbloom provides guided at-home ketamine therapy in the United States and has the largest published evidence base in at-home ketamine therapy. The company delivers clinician-supervised sublingual and subcutaneous ketamine as part of a comprehensive therapeutic program.

Mindbloom's care model is designed to optimize your environment by combining medical oversight with robust therapeutic support. Programs are organized into 6, 12, or 18 sessions, personalized based on your clinical needs and treatment goals. Mindbloom is also currently the only at-home provider offering subcutaneous administration, an alternative for clients who prefer injections or tried tablets and didn't like them.

As of October 2026, Mindbloom has facilitated over 900,000 clinician-supervised sessions. The company has published three peer-reviewed studies evaluating the safety and effectiveness of its specific protocol at scale.

A standard Mindbloom program includes:

  • Clinician consults: Telehealth visits for diagnosis, prescribing, progress management, and dosage adjustments.
  • Ketamine treatments: Sublingual tablets or subcutaneous injectables shipped directly to your home.
  • Guide coaching: 1:1 preparation and integration sessions with a dedicated guide.
  • Unlimited guide messaging: Ongoing support between your scheduled sessions.
  • Group Integration Circles: Unlimited access to guide-led group integration sessions.
  • Bloombox: An experiential toolkit containing an eye mask, journal, and session essentials.
  • Mindbloom App: Access to 10+ guided programs with 150+ custom soundscapes, preparation materials, and integration resources.

What Is IV Ketamine Therapy?

IV ketamine therapy is an in-clinic treatment where the medication is administered intravenously under direct medical supervision. These sessions typically take place in a specialized ketamine clinic, a psychiatric office, or an outpatient medical facility.

During an IV session, you sit or recline in a clinical setting while a nurse or medical professional monitors your vitals throughout the infusion. The intravenous delivery method provides approximately 100% bioavailability, meaning the entire dose reaches your bloodstream. Most clinics offer an initial series of infusions, often consisting of six sessions over two to three weeks, followed by maintenance infusions as needed.

IV ketamine is an established modality with decades of clinical use behind it. Practical considerations include travel to a clinic for each session, the cost per session, and what each clinic includes beyond the infusion itself.

A typical IV ketamine session involves:

  • Pre-session: Medical intake, a vitals check, and a review of informed consent.
  • During session: An IV line is placed, ketamine is infused over approximately 40 minutes, and on-site staff continuously monitor vitals.
  • Post-session: An observation period of 30 to 60 minutes occurs, followed by a vitals recheck and clearance to leave with arranged transportation.

Mindbloom vs IV Ketamine Administration Methods

Administration method refers to how ketamine enters your body during treatment. Each route has a different bioavailability, onset time, and set of practical considerations.

Sublingual Tablets

Sublingual tablets are small lozenges held between your cheek and gums for approximately seven minutes before being spit out. With a sublingual ketamine dose, effects typically begin within 10 to 15 minutes, and the bioavailability is roughly 30%. This needle-free option is self-administered at home, with your dose set by your clinician and adjusted between sessions as needed. Bioavailability affects onset speed and dose calculation, not outcomes on its own: in the largest published study of at-home ketamine therapy (n=11,441), sublingual dosing at ~30% bioavailability produced response and remission rates comparable to pooled in-clinic IV ketamine data (56.4% vs. 53.6% response; 28.1% vs. 28.9% remission).5,7

Subcutaneous Injection

Subcutaneous administration involves using a small insulin-type needle to inject the medication into your abdomen. The effects begin in about five minutes, and the bioavailability is 90% or higher. That doesn't by itself mean better outcomes, as the comparable sublingual and IV results above show. It means more of the dose reaches the bloodstream, and doses are calibrated accordingly. Injections give clients an alternative if they prefer them or tried tablets and didn't like them. Mindbloom injections are currently the only at-home subcutaneous option available.

IV Infusion

IV infusion delivers ketamine directly into your bloodstream via an intravenous line in a clinical setting. This method provides nearly 100% bioavailability and allows medical staff to execute precise, real-time dose titration. It requires travel to a clinic, the placement of an IV line, and a mandatory post-session observation period before you can be driven home.

Monitoring and Clinical Oversight for Mindbloom vs IV Clinics

Clinical oversight encompasses how each provider screens, monitors, and supports clients before, during, and after their ketamine sessions. Both models prioritize safety, but they execute their protocols differently.

IV clinics utilize on-site medical staff to monitor vitals continuously during the infusion. Blood pressure, heart rate, and oxygen saturation are tracked in real time, allowing a clinician to adjust the infusion rate or stop it immediately if necessary. Post-session observation also occurs on-site before you are cleared to leave with your arranged transportation.

Mindbloom provides clinical oversight through telehealth clinician consults. During every at-home session, you are required to have a peer treatment monitor present, a friend or family member you choose. Your Mindbloom guide walks them through the process and gives them the information and resources they need to feel comfortable in the role. They stay in a nearby room, checking in about every 15 minutes. You also have unlimited guide messaging, app-guided session protocols, and clear escalation protocols, including an on-call clinician.

Duration, Onset, and Post-Session Experience for Mindbloom vs IV Ketamine

Session timing—including the onset of action, active duration, and the post-session transition—varies significantly by administration route and setting. For IV ketamine, the onset is almost immediate once the infusion begins, and the active experience lasts about 40 minutes. The total clinic visit, including intake, observation, and clearance, typically takes two to three hours. You must arrange transportation home, as driving is not permitted until after a full night of sleep.

Mindbloom sublingual tablets have an onset of 10 to 15 minutes, with an active experience typically lasting between 45 and 60 minutes. Mindbloom subcutaneous injections have a faster onset of about five minutes, with a similar active duration. Both at-home methods require about two hours of total session time, including preparation and the post-session transition, but they eliminate all travel and waiting room time.

The post-session period is consistent across all routes: you must avoid driving or operating machinery until after a full night of sleep. Beyond that restriction, individual experiences vary. Some people prefer to keep their schedule clear for the day, while others feel ready to resume non-driving activities later that afternoon.

Care and Support Between Sessions for Mindbloom vs IV Clinics

Integration and between-session support refer to the preparation, coaching, and practices that happen outside of the ketamine session itself. These elements help translate acute therapeutic experiences into lasting behavioral change.

Support between sessions varies significantly among IV clinics. Some facilities pair infusions with psychotherapy, a practice known as ketamine-assisted psychotherapy (KAP). Other clinics focus on the infusion itself and refer clients to external therapists for integration support.

Mindbloom builds integration directly into its defined treatment framework. Every Mindbloom client works with a dedicated guide, a trained psychedelic integration specialist who helps them prepare for each session and turn what comes up into lasting change. Guides are hired with a coaching certification or 500+ hours of coaching experience with 50+ clients, complete Mindbloom's training protocol, and about 75% hold two or more certifications in areas like trauma healing or addiction recovery. Guides are part of a care team led by licensed clinicians, who handle evaluation, prescribing, and dosing, and guides share safety and progress updates with them.

Mindbloom's peer-reviewed outcomes come from clients receiving this same clinician-and-guide care. Between your 1:1 guide sessions, you have unlimited messaging with your guide, unlimited guide-led Group Integration Circles, and the Mindbloom App's journaling prompts and custom soundscapes.

Ketamine temporarily modulates neural communication to create conditions for change, but integration is what helps make that change durable. This is arguably the most significant structural difference between the two models: integration support is built into every Mindbloom program, while at IV clinics it varies by clinic.

Cost and Access for Mindbloom vs IV Ketamine

Cost and accessibility are among the most common decision factors when comparing at-home ketamine therapy to IV infusions. The financial and logistical commitments differ substantially between the two models.

As of October 2026, individual IV ketamine infusions typically range from $400 to $800 or more per session, with a standard six-infusion series totaling $2,000 to $6,000+, and because it is off-label for mood disorders, it is rarely covered by standard insurance. Geographic access is also limited to areas with specialized clinics, requiring travel, time off work, and arranged transportation for every visit.

Mindbloom is approximately 60% more affordable per session than typical IV ketamine clinics. A new client 6-session program is priced at $430 per month for three months, totaling $1,290. The 12-session program is $370 per month for six months ($2,220 total), and the 18-session program is $330 per month for nine months ($2,970 total). That works out to $165–$215 per session depending on program length—and every program includes clinician consults, guide coaching, and integration support, not just the medication. Mindbloom programs are HSA/FSA eligible, and the company provides superbills that you can submit for potential out-of-network reimbursement.

Safety Protocols and Screening for Mindbloom and IV Ketamine

Both at-home and in-clinic ketamine therapy require rigorous clinical screening and safety protocols. The approaches differ in their execution, not in whether safety measures exist.

Clinical screening evaluates your medical history to identify contraindications that could make ketamine therapy inappropriate. For example, ketamine can temporarily increase blood pressure and heart rate. Individuals with uncontrolled hypertension or active psychosis may not be appropriate candidates, which is why cardiovascular and psychiatric screening are critical parts of the intake process for any provider.

IV clinics typically conduct screening that includes a medical history review, a medication review, and sometimes bloodwork or an EKG. During the session, on-site staff monitor vitals continuously and can intervene immediately if blood pressure or heart rate elevate unexpectedly.

Mindbloom conducts screening via telehealth clinician consults that evaluate your medical history, psychiatric background, current medications, and treatment goals. During every session, a peer treatment monitor is required to be present, and clear escalation protocols include an on-call clinician. In Mindbloom's published safety data (Mathai et al., 2024), side effects occurred in approximately 4–5% of participants, serious adverse events in fewer than 0.1%, and discontinuation due to adverse events in 0.4%.5

Mindbloom Outcomes and Published Research

Mindbloom has published three peer-reviewed, real-world outcomes studies of at-home ketamine therapy, all evaluating safety and effectiveness specifically on Mindbloom clients using the Mindbloom clinical protocol: two sublingual studies in the Journal of Affective Disorders and a 2026 subcutaneous study, including PTSD outcomes, in the Journal of Medical Internet Research. Mindbloom has also published a preprint analysis of sleep outcomes.

  • Mathai et al. (2024): In a peer-reviewed study of 11,441 Mindbloom clients using sublingual tablets, 56.4% met criteria for depression response and 28.1% reached remission. Among the 7,776 with baseline anxiety scores, 56.1% met criteria for anxiety response and 28.8% reached remission. (Read the Mindbloom blog summary).5
  • Hull et al. (2022): In a prospective open-label study of 1,247 Mindbloom clients, 89% reported improvement in their symptoms after four sessions, 62.8% met depression response criteria, and 32.6% reached remission. (Read the Mindbloom blog summary).4
  • PTSD: In a peer-reviewed study of 3,041 Mindbloom clients using subcutaneous ketamine, 76.7% of those with PTSD met response criteria and 56.7% reached remission by the end of the six-session course, and 84.6% saw clinically meaningful improvement.6
  • Sleep outcomes preprint: In a real-world analysis of 13,963 Mindbloom clients (Swain J et al., 2026, preprint), 76.8% of clients who completed treatment met response criteria for sleep, with an average 48.8% improvement in sleep disturbance severity, and 2.5% reported worsened sleep.10

While direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures, Mindbloom's outcomes provide context for those considering treatment. Mindbloom's sublingual depression response (56.4%) and remission (28.1%) rates are comparable to those reported in selected IV ketamine studies.1 Additionally, Mindbloom's sublingual anxiety response rate is about 19% higher than the rate reported for CBT for generalized anxiety (56.1% vs. 47%), though the studies involved separate populations.11 Finally, Mindbloom's PTSD response rate (76.7%) is higher than the 27% to 41% response rates reported in a randomized trial of prolonged exposure therapy and sertraline, though the studies used different measures and response definitions.9

These results come from Mindbloom's own clients rather than from general ketamine literature. They also reflect Mindbloom's own protocol, including its dosing, session spacing, and guide-supported preparation and integration, which likely contributes to outcomes, so they don't carry over to providers using different protocols. IV ketamine clinics vary in whether they publish peer-reviewed outcomes from their own patients, and many rely on the broader ketamine literature when discussing expected results. Individual results may vary.

Should You Choose Mindbloom or IV Ketamine?

The right option depends entirely on your clinical needs, preferences, and circumstances. Neither modality is universally superior; they are simply different clinical approaches for different needs.

Mindbloom may be a good fit if you:

  • Want a comprehensive program with built-in coaching, integration, and community support.
  • Prefer the convenience and comfort of at-home sessions.
  • Value having both sublingual and subcutaneous administration options.
  • Want a provider with published peer-reviewed outcomes data on their own protocol.
  • Are looking for a more affordable option than IV infusion clinics.

IV ketamine may be a good fit if you:

  • Prefer in-person medical supervision with continuous vitals monitoring during sessions.
  • Prefer intravenous delivery with real-time dose titration by on-site medical staff.
  • Have a clinical profile that requires on-site medical oversight, as determined by a clinician.
  • Have access to a reputable IV ketamine clinic near your home.
  • Prefer a clinical environment for your mental health treatments.

Both options are clinically established approaches to ketamine therapy. The decision is preference-sensitive and should be shaped by your medical needs, budget, and how much therapeutic support you want around the experience itself.

Disclaimer and Safety Information

Ketamine therapy requires evaluation by a licensed clinician to determine if it is medically appropriate for you. This content is for informational purposes only and does not constitute medical advice. Individual results vary by patient and condition. If you are in crisis, please contact the 988 Suicide & Crisis Lifeline immediately.

Frequently asked questions

Is Mindbloom or IV ketamine safer for mental health treatment?

Safety depends on clinical screening, protocol adherence, and oversight rather than setting alone. In Mindbloom's published peer-reviewed studies, serious adverse events occurred in fewer than 0.1% of participants.

Which ketamine therapy option is more affordable?

Mindbloom is approximately 60% more affordable per session than typical IV ketamine clinics. Additionally, Mindbloom programs include clinician consults, guide coaching, and integration support, rather than just the medication itself.

Does Mindbloom have published research on its own treatment protocol?

Yes. Mindbloom has published three peer-reviewed studies evaluating safety and effectiveness specifically on Mindbloom clients using the Mindbloom protocol: two in the Journal of Affective Disorders (Hull et al. 2022, Mathai et al. 2024) and one on subcutaneous injections in the Journal of Medical Internet Research (Parks et al. 2026).

Can you switch from an IV ketamine clinic to Mindbloom?

Yes, many Mindbloom clients have previously received IV ketamine infusions. A Mindbloom clinician will evaluate your medical history and treatment goals during the intake consult to determine the appropriate program and dosing.

Does insurance cover Mindbloom or IV ketamine infusions?

Ketamine therapy is not typically covered by standard insurance plans because it is prescribed off-label for mood disorders. Off-label prescribing itself is legal and common: about 21% of U.S. office-based prescriptions are written for off-label uses (Radley et al., 2006). Mindbloom is HSA/FSA eligible and provides superbills that clients can submit for potential out-of-network reimbursement.

What is the difference between Mindbloom sublingual tablets and subcutaneous injectables?

Mindbloom Tablets are sublingual lozenges held in the mouth, while Injectables are administered subcutaneously via a small needle into the abdomen. Injectables give clients an alternative route if they prefer them or tried tablets and didn't like them. Higher bioavailability doesn't by itself mean better outcomes: Mindbloom clients using sublingual tablets (about 30% bioavailability) showed depression response comparable to in-clinic IV ketamine (close to 100%), 56.4% by session 4 (Mathai 2024) vs. 53.6% (McInnes 2022). Doses are calibrated to each route.

How quickly does ketamine therapy work for depression and anxiety?

Many people report noticeable symptom improvement within hours or days of their first session, regardless of the administration route. More durable and cumulative benefits typically develop over a series of sessions combined with integration practices.

Mindbloom Treatment

HSA/FSA ELIGIBLE
4.7/5

See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.

Get started

Keep us top of mind in your inbox.

Thank you! You're now registered!
Oops! Something went wrong while submitting the form.

In this article

Text 1
0 References

Authors

Explore related articles

No items found.
No items found.